Search research articles
Contact Us
Filters
Showing results (1-10 of 255) with videos related to
Page
of 26
Sort By:
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy
|
August 11, 2001
Does P-glycoprotein play a role in anticancer drug pharmacokinetics?
Alex Sparreboom, Kees Nooter
Pharmacogenomics
|
August 7, 2008
Pharmacogenomic importance of ABCG2
George Cusatis, Alex Sparreboom
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 15, 2015
CCR 20th anniversary commentary: BMS-247550—microtubule stabilization as successful targeted therapy
Navjotsingh Pabla, Alex Sparreboom
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 4, 2023
Unique Cabozantinib Dosing Considerations in People Living with HIV and Cancer
Eric D Eisenmann, Alex Sparreboom
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
January 1, 2014
Uptake carriers and oncology drug safety
Jason A Sprowl, Alex Sparreboom
Current Clinical Pharmacology
|
April 22, 2010
Pharmacogenetics of irinotecan disposition and toxicity: a review
Ken-ichi Fujita, Alex Sparreboom
Nature Reviews. Clinical Oncology
|
July 17, 2013
Chemotherapy dosing in overweight and obese patients with cancer
Gary H Lyman, Alex Sparreboom
European Journal of Cancer (Oxford, England : 1990)
|
November 19, 2005
Peripheral neuropathy: a persisting challenge in paclitaxel-based regimes
Stephan Mielke, Alex Sparreboom, Klaus Mross
Methods in Molecular Biology (Clifton, N.J.)
|
September 6, 2022
Pharmacogenomics in Cytotoxic Chemotherapy of Cancer
Zahra Talebi, Alex Sparreboom, Susan I Colace
Clinical Pharmacokinetics
|
March 3, 2006
Clinical pharmacokinetics of docetaxel : recent developments
Sharyn D Baker, Alex Sparreboom, Jaap Verweij
Page
of 26
Search research articles
Search
Showing results (1-10 of 255) with videos related to
Sort By:
Page
of 26
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy
|
August 11, 2001
Does P-glycoprotein play a role in anticancer drug pharmacokinetics?
Alex Sparreboom, Kees Nooter
Pharmacogenomics
|
August 7, 2008
Pharmacogenomic importance of ABCG2
George Cusatis, Alex Sparreboom
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 15, 2015
CCR 20th anniversary commentary: BMS-247550—microtubule stabilization as successful targeted therapy
Navjotsingh Pabla, Alex Sparreboom
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 4, 2023
Unique Cabozantinib Dosing Considerations in People Living with HIV and Cancer
Eric D Eisenmann, Alex Sparreboom
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
January 1, 2014
Uptake carriers and oncology drug safety
Jason A Sprowl, Alex Sparreboom
Current Clinical Pharmacology
|
April 22, 2010
Pharmacogenetics of irinotecan disposition and toxicity: a review
Ken-ichi Fujita, Alex Sparreboom
Nature Reviews. Clinical Oncology
|
July 17, 2013
Chemotherapy dosing in overweight and obese patients with cancer
Gary H Lyman, Alex Sparreboom
European Journal of Cancer (Oxford, England : 1990)
|
November 19, 2005
Peripheral neuropathy: a persisting challenge in paclitaxel-based regimes
Stephan Mielke, Alex Sparreboom, Klaus Mross
Methods in Molecular Biology (Clifton, N.J.)
|
September 6, 2022
Pharmacogenomics in Cytotoxic Chemotherapy of Cancer
Zahra Talebi, Alex Sparreboom, Susan I Colace
Clinical Pharmacokinetics
|
March 3, 2006
Clinical pharmacokinetics of docetaxel : recent developments
Sharyn D Baker, Alex Sparreboom, Jaap Verweij
Page
of 26